TÌNH HÌNH SỬ DỤNG THUỐC HẠ HUYẾT ÁP TRÊN BỆNH NHÂN SUY THẬN MẠN LỌC MÁU CHU KỲ BẰNG THẬN NHÂN TẠO TẠI BỆNH VIỆN ĐA KHOA TỈNH KIÊN GIANG NĂM 2021

Abstract

Background: End-stage chronic kidney disease must be treated with hemodialysis, which increases the burden of treatment costs and increases mortality. The selection of antihypertensive drugs in this patients should be considered to ensure safety. Objectives: To determine the rate of use and evaluate the rationality of antihypertensive drugs in patients. Materials and methods: Descriptive cross-sectional study, performed on the outpatient medical records of patients with chronic renal failure with indications for hemodialysis at the Department of Nephrology and Dialysis - Kien Giang Provincial General Hospital in 2021. Data processing using SPSS 20.0 software. Results: Over 384 outpatient medical records of different patients surveyed had a mean age of 48.1±13.6. The mean number of antihypertensive drugs in a single prescription was 3.4±0.9. The group of drugs used the most was calcium channel blockers with the rate of 85.2%. The combination regimen of 3 drug groups accounted for the highest rate of 41.2%. The combination of 3 groups of angiotensin receptor blockers, calcium channel blockers, and diuretics is the most indicated. The rate of reasonable use of antihypertensive drugs was 50.8%. Conclusions: Calcium channel blockers are the treatment used in most patients. Combination regimen of 3 classes of antihypertensive drugs is preferred in patients undergoing hemodialysis with hemodialysis. The rate of reasonable use of antihypertensive drugs was 50.8%.